MachineMD is a medtech company developing automated tools for neurological examination based on eye movements and reflexes. Its core product, NeuroLens, is a headset-based system that performs a range of neuro-ophthalmic tests to support earlier and more objective detection of brain disorders. By combining eye tracking, pupil measurement, and software analysis, the platform is designed to translate established neurological exams into a standardized digital format. MachineMD positions the technology as a way to improve diagnostic speed, consistency, and accessibility across clinical settings.

The system presents controlled visual stimuli while embedded sensors record eye movements, pupil responses, and related visual function metrics. These measurements are analyzed quantitatively to detect abnormalities that may reflect neurological dysfunction. By automating multiple exam components within a single device, the platform reduces reliance on subjective bedside assessment and specialist interpretation. This creates a more structured and repeatable way to capture neuro-ophthalmic biomarkers.

MachineMD’s technology is aimed at both acute and outpatient neurology use cases, including stroke assessment, neurodegenerative disease screening, and longitudinal monitoring. Its broader relevance lies in turning eye-based neurological signs into scalable clinical data. The company sits within a growing segment of neurodiagnostic tools using sensors, software, and AI to modernize routine examination.